On the origin of matrix metalloproteinase-2 and -9 in blood platelets

Platelets

Volumn 23, Issue 6, 2012, Pages 467-474

  Wrzyszcz, Aneta ^a   Wozniak, Mieczyslaw ^a,b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Matrix metalloproteinase; Platelets

Indexed keywords

GELATINASE A; GELATINASE B; MESSENGER RNA;

ARTICLE; CELL ISOLATION; CELL POPULATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME RELEASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MEGAKARYOBLAST; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE VOLUME; WESTERN BLOTTING; ZYMOGRAPHY;

ARTIFACTS; BLOOD PLATELETS; BLOTTING, WESTERN; CELL LINE; CELL SEPARATION; CELL SIZE; ENZYME PRECURSORS; FLOW CYTOMETRY; HUMANS; LEUKOCYTES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MEGAKARYOCYTE PROGENITOR CELLS; PLATELET ACTIVATION; RNA, MESSENGER; THROMBIN; TRANSCRIPTION, GENETIC;

EID: 84864859582     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2012.682103     Document Type: Article

References (32)

1. Goetzl EJ, Banda MJ, Leppert D. Matrix metalloproteinases in immunity. J Immunol 1996;156:1-4.
2. Lane WJ, Dias S, Hattori K, Heissig B, Choy M, Rabbany SY, Wood J, Moore MAS, Rafii S. Stromalderived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases. Blood 2000;96:4152-4159.
3. Sawicki G, Salas E, Murat J, Miszta-Lane H, Radomski MW. Release of gelatinase A during platelet activation mediates aggregation. Nature 1997;386:616-619.
4. Santos-Martinez MJ, Medina C, Jurasz P, Radomski MW. Role of metalloproteinases in platelet function. Thromb Res 2007;121:535-542.
5. Falcinelli E, Guglielmini G, Torti M, Gresele P. Intraplatelet signaling mechanisms of the priming effect of matrix metalloproteinase-2 on platelet aggregation. J Thromb Haemost 2005;3:2526-2535.
6. Fernandez-Patron C, Martinez-Cuesta SE, Sawicki G, Wozniak M, Radomski MW, Davidge ST. Differential regulation of platelet aggregation by matrix metalloproteinase-9 and 2. Thromb Haemost 1999;82:1730-1735.
7. Choi W-S, Jeon O-H, Kim H-H, Kim D-S. MMP-2 regulates human platelet activation by interacting with integrin -IIb-3. J Thromb Haemost 2008;6:517-23.
8. Sheu JR, Fong TH, Liu CM, Shen MY, Chen TL, Chang Y, Lu MS, Hsiao G. Expression of matrix metalloproteinase-9 in human platelets: Regulation of platelet activation in in vitro and in vivo studies. Br J Pharmacol 2004;143:193-201.
9. Lee YM, Lee JJ, Shen MY, Hsiao G, Sheu JR. Inhibitory mechanisms of activated matrix metalloproteinase-9 on platelet activation. Br J Pharmacol 2006;537:52-58.
10. Jurasz P, Chung AWY, Radomski A, Radomski MW. Nonremodeling properties of matrix metalloproteinases: The platelet connection. Circ Res 2002;90:1041-1043.
11. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: The good, the bad, and the ugly. Circ Res 2002;90:251-262.
12. Jurasz P, Sawicki G, Duszyk M, Sawicka J, Miranda C, Mayers I, Radomski MW. Matrix metalloproteinase-2 in tumor-cell induced platelet aggregation: Regulation by NO. Cancer Res 2001;61:376-382.
13. Galt SW, Lindemann S, Allen L, Medd DJ, Falk JM, McIntyre TM, Prescott SM, Kraiss LW, Zimmerman GA, Weyrich AS. Outside-in signals delivered by matrix metalloproteinase-1 regulate platelet function. Circ Res 2002;90:1093-1099.
14. Colciaghi FB, Pastorino L, Marcello E, Zimmermann M, Cattabeni F, Padovani A, Di Luca M. [Alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients. Mol Med 2002;8:67-74.
15. Bergmeier W, Piffath CL, Cheng G, Dole VS, Zhang Y, von Andrian UH, Wagner DD. Tumor necrosis factor-{alpha}-converting enzyme (ADAM17) mediates gpib{alpha}shedding from platelets in vitro and in vivo. Circ Res 2004;95:677-683.
16. Rabie T, Strehl A, Ludwig A, Nieswandt B. Evidence for a role of ADAM17 (TACE) in the regulation of platelet glycoprotein V. J Biol Chem 2005;280:14462-14468.
17. Galt SW, Lindemann S, Medd D, Allen LL, Kraiss LW, Harris ES, Prescot SM, McIntyre TM, Weyrich AS, Zimmerman GA. Differential regulation of Matrix Metalloproteinase-9 by monocytes adherent to collagen and platelets. Circ Res 2001;89:509-516.
18. Lindenmeyer F, Legrand Y, Menashi S. Upregulation of MMP-9 expression in MDA-MB231 tumor cells by platelet granular membrane. FEBS Lett 1997;418:19-22.
19. Kälvegren H, Jönsson S, Jonasson L. Release of matrix metalloproteinases-1 and -2, but not -9, from activated platelets measured by enzyme-linked immunosorbent assay. Platelets 2011;22:572-578.
20. Cecchetti L, Tolley ND, Michetti N, Bury L, Weyrich AS, Gresele P. Megakaryocytes differentially sort mRNAs for matrix metalloproteinases and their inhibitors into platelets: A mechanism for regulating synthetic events. Blood 2011;118: 1903-1911.
21. Mustard JF, Perry DW, Ardli NG, Packham MA. Preparation of suspension of washed platelets from humans. Br J Haematol 1972;22:193-204.
22. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
23. Emara M, Wozniak M. In vitro inhibition of human MMP-2 collagenolytic and gelatinolytic activity by neutralizing monoclonal antibodies. Immunol Invest 2010;39:833-848.
24. Leber TM, Balkwill FR. Zymography: A single-step staining method for quantitation of proteolytic activity on substrate gels. Anal Biochem 1997;249:24-28.
25. Sawicki G, Sanders EJ, Salas E, Wozniak M, Rodrigo J, Radomski MW. Localization and translocation of MMP-2 during aggregation of human platelets. Thromb Haemost 1998;80:836-839.
26. Ault KA, Rinder HM, Mitchell J, Carmody MB, Vary CPH, Hillman RS. The significance of platelets with increased RNA content (reticulated platelets): A measure of the rate of thrombopoiesis. Am J Clin Pathol 1992;98:637-646.
27. Harrison P, Wilbourn B, Debili N, Vainchenker J, Breton-Gorius J, Lawrie AS, Masse JM, Savidge GF, Cramer EM. Uptake of plasma fibrinogen into the alpha granules of human megakaryocytes and platelets. J Clin Invest 1989;84: 1320-1324.
28. Werb Z. ECM and cell surface proteolysis: Regulating cellular ecology. Cell 1997;91:439-442.
29. Tayebjee MH, Lip GYH, Blann AD, MacFadyen RJ. Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2. Thromb Res 2005;115:205-210.
30. Ray JM, Stetler-Stevenson WG. The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur Respir J 1994;7:2062-2072.
31. Falcinelli E, Bury L, Tolley N, Malvestiti M, Cecchetti L, Weyrich A, Gresele P. Response: MMP-9 in platelets: Maybe, maybe not. Blood 2011;118:6471-6473.
32. Mannello F, Medda V. Differential expression of MMP-2 and MMP-9 activity in megakaryocytes and platelets. Blood 2011; 118:6470-6471.